“Efficacy and safety of topical mometasone furoate 0.01% vs. tacrolimus 0.03% and mometasone furoate 0.01%in vitiligo”, J Pak Assoc Dermatol, vol. 20, no. 2, pp. 89–92, Dec. 2016, doi: 10.66344/jpad.v20i2.427.